JP2022538497A5 - - Google Patents

Info

Publication number
JP2022538497A5
JP2022538497A5 JP2022500533A JP2022500533A JP2022538497A5 JP 2022538497 A5 JP2022538497 A5 JP 2022538497A5 JP 2022500533 A JP2022500533 A JP 2022500533A JP 2022500533 A JP2022500533 A JP 2022500533A JP 2022538497 A5 JP2022538497 A5 JP 2022538497A5
Authority
JP
Japan
Application number
JP2022500533A
Other languages
Japanese (ja)
Other versions
JPWO2021003442A5 (https=
JP2022538497A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/040770 external-priority patent/WO2021003442A1/en
Publication of JP2022538497A publication Critical patent/JP2022538497A/ja
Publication of JP2022538497A5 publication Critical patent/JP2022538497A5/ja
Publication of JPWO2021003442A5 publication Critical patent/JPWO2021003442A5/ja
Pending legal-status Critical Current

Links

JP2022500533A 2019-07-02 2020-07-02 ライソゾーム蓄積症を処置するためのベクター組成物およびそれを使用する方法 Pending JP2022538497A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962869808P 2019-07-02 2019-07-02
US201962869781P 2019-07-02 2019-07-02
US62/869,808 2019-07-02
US62/869,781 2019-07-02
PCT/US2020/040770 WO2021003442A1 (en) 2019-07-02 2020-07-02 Vector compositions and methods of using same for treatment of lysosomal storage disorders

Publications (3)

Publication Number Publication Date
JP2022538497A JP2022538497A (ja) 2022-09-02
JP2022538497A5 true JP2022538497A5 (https=) 2023-07-13
JPWO2021003442A5 JPWO2021003442A5 (https=) 2023-07-13

Family

ID=72046993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022500533A Pending JP2022538497A (ja) 2019-07-02 2020-07-02 ライソゾーム蓄積症を処置するためのベクター組成物およびそれを使用する方法

Country Status (10)

Country Link
US (1) US12492412B2 (https=)
EP (1) EP3994253A1 (https=)
JP (1) JP2022538497A (https=)
KR (1) KR20220069917A (https=)
CN (1) CN114616000A (https=)
AU (1) AU2020298575A1 (https=)
BR (1) BR112021026866A2 (https=)
CA (1) CA3145662A1 (https=)
TW (1) TW202122579A (https=)
WO (1) WO2021003442A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024505885A (ja) * 2021-01-27 2024-02-08 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル リソソーム酸リパーゼ欠損症(lal-d)の治療のための材料及び方法
CN113238053B (zh) * 2021-04-30 2022-05-13 四川大学华西医院 一种用于检测stat3二聚化的质粒
WO2023150051A1 (en) * 2022-02-04 2023-08-10 M6P Therapeutics, Inc. Compositions and methods of using two-promoter vector for treatment of lysosomal storage disorders
WO2023150388A1 (en) * 2022-02-07 2023-08-10 M6P Therapeutics, Inc. Compositions comprising glucocerebrocidase and methods of use thereof
WO2025238106A1 (en) 2024-05-15 2025-11-20 M6P Therapeutics (Switzerland) GmbH Lysosome-targeting degradation fusion design
CN119950766A (zh) * 2025-02-11 2025-05-09 中国医学科学院阜外医院 一种治疗pnpla2突变致心律失常性心肌病的基因药物及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
US5350674A (en) 1992-09-04 1994-09-27 Becton, Dickinson And Company Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
CA2386270A1 (en) 1999-10-15 2001-04-26 University Of Massachusetts Rna interference pathway genes as tools for targeted genetic interference
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
AU2001275474A1 (en) 2000-06-12 2001-12-24 Akkadix Corporation Materials and methods for the control of nematodes
NZ532635A (en) 2001-11-13 2007-05-31 Univ Pennsylvania A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
CN1856576B (zh) 2003-09-30 2011-05-04 宾夕法尼亚州立大学托管会 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
PT2561069T (pt) * 2010-04-23 2017-05-22 Alexion Pharma Inc Enzima de doença de armazenamento lisossomal
US20150030582A1 (en) 2010-04-23 2015-01-29 Synageva Biopharma Corp. Lysosomal Storage Disease Enzyme
US10722559B2 (en) * 2014-08-11 2020-07-28 Shire Human Genetic Therapies, Inc. Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
WO2018064667A1 (en) * 2016-09-30 2018-04-05 Washington University COMPOSITIONS COMPRISING A MODIFIED GlcNAc-1-PHOSPHOTRANSFERASE AND METHODS OF USE THEREOF

Similar Documents

Publication Publication Date Title
JP2022538497A5 (https=)
JPWO2022185614A1 (https=)
CN305858417S (https=)
CN305528016S (https=)
CN305536657S (https=)
CN305535524S (https=)
CN305537012S (https=)
CN305532194S (https=)
CN305531713S (https=)
CN305530534S (https=)
CN305816264S (https=)
CN305823061S (https=)
CN305637980S (https=)
CN305702140S (https=)
CN306026428S (https=)
CN306020241S (https=)
CN305663616S (https=)
CN306003458S (https=)
CN305980678S (https=)
CN305965535S (https=)
CN305965149S (https=)
CN305949962S (https=)
CN305948181S (https=)
CN305947181S (https=)
CN305537001S (https=)